A Novel Peptide Agonist of Formyl-Peptide Receptor-Like 1 (ALX) Displays Anti-Inflammatory and Cardioprotective Effects-Reference-Cited by-同舟云学术

A Novel Peptide Agonist of Formyl-Peptide Receptor-Like 1 (ALX) Displays Anti-Inflammatory and Cardioprotective Effects

Published:2008-11-20 Issue:2 Volume:328 Page:426-434
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Hecht Iris,Rong Jiang,Sampaio André L. F.,Hermesh Chen,Rutledge Caleb,Shemesh Ronen,Toporik Amir,Beiman Merav,Dassa Liat,Niv Hagit,Cojocaru Gady,Zauberman Arie,Rotman Galit,Perretti Mauro,Vinten-Johansen Jakob,Cohen Yossi

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference40 articles.

1. A Novel Effect for Annexin 1-Derived Peptide Ac2-26: Reduction of Allergic Inflammation in the Rat

2. Cutting Edge: Lipoxin (LX) A4and Aspirin-Triggered 15-Epi-LXA4Block Allergen-Induced Eosinophil Trafficking

3. Lipoxins and novel 15-epi-lipoxin analogs display potent anti-inflammatory actions after oral administration

4. The Lipoxin Receptor ALX: Potent Ligand-Specific and Stereoselective Actions in Vivo

5. The Synthetic Peptide Trp-Lys-Tyr-Met-Val-Met-NH2 Specifically Activates Neutrophils through FPRL1/Lipoxin A4 Receptors and Is an Agonist for the Orphan Monocyte-expressed Chemoattractant Receptor FPRL2

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Annexin-A1 mimetic RTP-026 promotes acute cardioprotection through modulation of immune cell activation;Pharmacological Research;2023-12

2. Developmental and homeostatic signaling transmitted by the G-protein coupled receptor FPR2;International Immunopharmacology;2023-05

3. Acute-serum amyloid A and A-SAA-derived peptides as formyl peptide receptor (FPR) 2 ligands;Frontiers in Endocrinology;2023-02-03

4. Resolution Pharmacology: Focus on Pro-Resolving Annexin A1 and Lipid Mediators for Therapeutic Innovation in Inflammation;Annual Review of Pharmacology and Toxicology;2023-01-20

5. Formyl peptide receptor 2 as a potential therapeutic target for inflammatory bowel disease;Acta Pharmacologica Sinica;2022-07-15